Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents

Author： Miot-Noirault Elisabeth

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.29, Iss.3, 2011-06, pp. : 424-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and antitumour activity of a new series of nitrosoureido sugars

By Monneret C. Risse S. Ardouin P. Gouyette A.

European Journal of Medicinal Chemistry, Vol. 35, Iss. 1, 2000-01 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Antitumor activity of imidazole derivatives: dacarbazine and the new alkylating agent imidazene (Review)

By Iradyan M. Iradyan N. Stepanyan G. Arsenyan F. Garibdzhanyan B.

Pharmaceutical Chemistry Journal, Vol. 44, Iss. 4, 2010-08 ,pp. : 175-182

Springer Publishing Company

Access to resources Recommend Favorite

The development of pyrrolobenzodiazepines as antitumour agents

By Hartley John A

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 733-744

Informa Healthcare

Access to resources Recommend Favorite

DNA minor groove alkylating agents

By Denny W.A.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 4, 2000-04 ,pp. : 459-474

Informa Healthcare

Access to resources Recommend Favorite

DNA Minor Groove Alkylating Agents

Current Medicinal Chemistry, Vol. 8, Iss. 5, 2000-05 ,pp. : 533-544

Bentham Science Publishers

Access to resources Recommend Favorite